These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31018071)

  • 21. (Hydroxy)-chloroquine retinal toxicity: two case reports and safety guidelines.
    Herman K; Leys A; Spileers W
    Bull Soc Belge Ophtalmol; 2002; (284):21-9. PubMed ID: 12161987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review.
    Geamănu Pancă A; Popa-Cherecheanu A; Marinescu B; Geamănu CD; Voinea LM
    J Med Life; 2014 Sep; 7(3):322-6. PubMed ID: 25408748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine screening.
    Lee AG
    Br J Ophthalmol; 2005 May; 89(5):521-2. PubMed ID: 15834072
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydroxychloroquine Screening Alert: Change is in the Wind.
    Marmor MF
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine.
    Penrose PJ; Tzekov RT; Sutter EE; Fu AD; Allen AW; Fung WE; Oxford KW
    Retina; 2003 Aug; 23(4):503-12. PubMed ID: 12972762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of red amsler grid screening in a rheumatology clinic.
    Pluenneke AC; Blomquist PH
    J Rheumatol; 2004 Sep; 31(9):1754-5. PubMed ID: 15338495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in ophthalmic monitoring for hydroxychloroquine toxicity.
    Gorovoy I; Gorovoy JB
    J Clin Rheumatol; 2013 Jan; 19(1):46-7. PubMed ID: 23319025
    [No Abstract]   [Full Text] [Related]  

  • 28. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic findings in chloroquine maculopathy.
    Halfeld Furtado de Mendonça R; Maia OO; Yukihiko Takahashi W
    Doc Ophthalmol; 2007 Sep; 115(2):117-9. PubMed ID: 17562091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atypical hydroxychloroquine maculopathy in an Asian woman with lupus].
    Messiant V; Defoort-Dhellemmes S; Smirnov V
    J Fr Ophtalmol; 2019 Dec; 42(10):1134-1136. PubMed ID: 31285064
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina.
    Mondal K; Porter H; Cole J; Pandya HK; Basu SK; Khanam S; Chiu CY; Shah V; Stephenson DJ; Chalfant CE; Mandal N
    Mol Neurobiol; 2022 Jun; 59(6):3873-3887. PubMed ID: 35426574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis.
    Leckie MJ; Rees RG
    Rheumatology (Oxford); 2002 Apr; 41(4):473-4. PubMed ID: 11961185
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydroxychloroquine-induced hyperpigmentation.
    Cho EB; Kim BC; Park EJ; Kwon IH; Cho HJ; Kim KH; Kim KJ
    J Dermatol; 2012 Oct; 39(10):859-60. PubMed ID: 22671572
    [No Abstract]   [Full Text] [Related]  

  • 34. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
    Unübol M; Ayhan M; Guney E
    J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846
    [No Abstract]   [Full Text] [Related]  

  • 36. Implanted pacemaker failure caused by the antirheumatic drug hydroxychloroquine.
    Huang PH; Tuan TC; Lin YJ; Ding YA; Kong CW
    Lupus; 2003; 12(9):725-7. PubMed ID: 14514140
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chloroquine and hydroxychloroquine maculopathy: a review of diagnostic and therapeutic guidelines in Hungarian and international clinical practice].
    Fodor M; Lukács MÁ; Szekanecz Z; Nagy ZZ
    Orv Hetil; 2024 Jul; 165(30):1147-1153. PubMed ID: 39068644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methoxsalen-induced advanced bull's eye maculopathy.
    Ranjan R; Manayath GJ; Salian R; Narendran V
    Eur J Ophthalmol; 2021 May; 31(3):NP70-NP73. PubMed ID: 32064940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation.
    True DG; Bryant LR; Harris MD; Bernert RA
    Arthritis Rheum; 2002 Jun; 46(6):1698. PubMed ID: 12115210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.